Silver Book Fact

Women taking vitamins B6 and B12 and folic acid–as compared to women not taking these supplements–were found to have a 34% lower risk of age-related macular degeneration (AMD) and a 41% lower risk of the advanced form.

Christen, William G., Robert J. Glynn, Emily Y. Chew, Christine M. Albert, and JoAnn E. Manson. Folic Acid, Pyridoxine, and Cyanocobalamin Combination Treatment and Age-Related Macular Degeneration in Women. Arch Intern Med. Feburary 2009; 169(4): 335-41. http://archinte.ama-assn.org/cgi/reprint/169/4/335

Reference

Title
Folic Acid, Pyridoxine, and Cyanocobalamin Combination Treatment and Age-Related Macular Degeneration in Women
Publication
Arch Intern Med
Publication Date
Feburary 2009
Authors
Christen, William G., Robert J. Glynn, Emily Y. Chew, Christine M. Albert, and JoAnn E. Manson
Volume & Issue
Volume 169, Issue 4
Pages
335-41
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Gene transfer process treatment for diabetic retinopathy
    A gene transfer process that produces a VEGF receptor prevents retinal vascular permeability (RVP) associated with diabetes that could have value in treating diabetic retinopathy.  
  • Current treatments for proliferative diabetic retinopathy have reduced the rate of blindness within 5 years from 50% to less than 5%.  
  • Timely treatment and follow-up care can reduce the risk of blindness in individuals with proliferative retinopathy by 95%.  
  • Screening and treatment for diabetic retinopathy in type 2 diabetes patients produces annual savings of 53,986 person-years of sight.  
  • In general, every 10 mmHg reduction in systolic blood pressure reduces the risk of diabetes complications by 12%.